Cargando…

Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination

BACKGROUND: The cost-effectiveness of universal rotavirus (RV) vaccination is controversial in developed countries. As a result, RV vaccination programs do not currently exist in most European countries. Hospitalization is the main driver of RV disease costs, and prematurity, low birth weight (LBW)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruijning-Verhagen, Patricia, Mangen, Marie-Josée J, Felderhof, Mariet, Hartwig, Nico G, van Houten, Marlies, Winkel, Léon, de Waal, Wouter J, Bonten, Marc JM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665442/ https://www.ncbi.nlm.nih.gov/pubmed/23622110 http://dx.doi.org/10.1186/1741-7015-11-112

Ejemplares similares

Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting
por: Bruijning-Verhagen, P., et al.
Publicado: (2018)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
por: Rozenbaum, Mark H, et al.
Publicado: (2011)

Cost-effectiveness of Rotavirus vaccination in Vietnam
por: Kim, Sun-Young, et al.
Publicado: (2009)

Cost-effectiveness of rotavirus vaccination in Mozambique
por: Lourenço Guimarães, Esperança, et al.
Publicado: (2022)

Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines
por: Debellut, Frédéric, et al.
Publicado: (2022)

Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
por: Pecenka, Clint, et al.
Publicado: (2018)

Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP
por: Mangen, Marie-Josée J, et al.
Publicado: (2013)

Impact and cost-effectiveness of rotavirus vaccination in Bangladesh
por: Pecenka, Clint, et al.
Publicado: (2017)

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
por: Mangen, Marie-Josée J., et al.
Publicado: (2015)

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
por: Tu, Hong Anh T, et al.
Publicado: (2013)

Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC)
por: de Hoog, Marieke L. A., et al.
Publicado: (2018)

Cost effectiveness of a pentavalent rotavirus vaccine in Oman
por: Al Awaidy, Salah Thabit, et al.
Publicado: (2014)

Dynamic Modeling of Cost-effectiveness of Rotavirus Vaccination, Kazakhstan
por: Freiesleben de Blasio, Birgitte, et al.
Publicado: (2014)

Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam
por: Riewpaiboon, Arthorn, et al.
Publicado: (2016)

Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2018)

Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness
por: Owusu, Richmond, et al.
Publicado: (2023)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Cost-Effectiveness of Rotavirus Vaccination for Under-Five Children in Iran
por: Shakerian, Sareh, et al.
Publicado: (2015)

Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study
por: Villanueva-Uy, Maria Esterlita T., et al.
Publicado: (2021)

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
por: Knoll, Stefanie, et al.
Publicado: (2013)

Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania
por: Ruhago, George M, et al.
Publicado: (2015)

Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia
por: Lusvan, Munkh-Erdene, et al.
Publicado: (2019)

Re–evaluation of the cost–effectiveness and effects of childhood rotavirus vaccination in Norway
por: Hansen Edwards, Christina, et al.
Publicado: (2017)

Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation
por: Suijkerbuijk, Anita WM, et al.
Publicado: (2020)

Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016)

Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016)

Baseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012
por: Gadroen, Kartini, et al.
Publicado: (2017)

Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain
por: Orrico-Sanchez, Alejandro, et al.
Publicado: (2017)

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
por: Valencia-Mendoza, Atanacio, et al.
Publicado: (2008)

Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031
por: Nonvignon, Justice, et al.
Publicado: (2018)

Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico
por: Gomez, Jorge, et al.
Publicado: (2023)

Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage
por: Costantino, Claudio, et al.
Publicado: (2018)

Rotaviruses and Rotavirus Vaccines
por: Donato, Celeste M., et al.
Publicado: (2021)

Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted
por: Thomas, Sara L., et al.
Publicado: (2017)

A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda
por: Ngabo, Fidèle, et al.
Publicado: (2015)

Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial
por: van Werkhoven, Cornelis H., et al.
Publicado: (2017)

Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data
por: Bar-Zeev, Naor, et al.
Publicado: (2016)

Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
por: Bhan, Anant, et al.
Publicado: (2011)

Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria
por: Anderson, John D., et al.
Publicado: (2020)

Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost–benefit analysis
por: Okafor, Charles E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k84ftvhthqh8u7qlcrp5obr7j2